APA (7th ed.) Citation

Fu, Q., Shen, Q., Tong, J., Huang, L., Cheng, Y., & Zhong, W. (2021). Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Fu, Qiang, Qian Shen, Jin Tong, Liu Huang, Yi Cheng, and Wei Zhong. Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Fu, Qiang, et al. Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A, 2021.